CN108243607A - 用于免疫疗法的巨噬细胞的遗传工程 - Google Patents

Info

Publication number

CN108243607A

CN108243607A CN201680065510.4A CN201680065510A CN108243607A CN 108243607 A CN108243607 A CN 108243607A CN 201680065510 A CN201680065510 A CN 201680065510A CN 108243607 A CN108243607 A CN 108243607A

Authority

CN

China

Prior art keywords

alternatives

cells

cell

immunocyte

protein

Prior art date

2015-09-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 210000002540 macrophage Anatomy 0.000 title claims description 96
• 238000009169 immunotherapy Methods 0.000 title description 10
• 238000010353 genetic engineering Methods 0.000 title description 5
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 332
• 210000004027 cell Anatomy 0.000 claims abstract description 225
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 188
• 239000013598 vector Substances 0.000 claims abstract description 185
• 210000002865 immune cell Anatomy 0.000 claims abstract description 181
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 172
• 238000000034 method Methods 0.000 claims abstract description 149
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims abstract description 125
• 210000001744 T-lymphocyte Anatomy 0.000 claims abstract description 99
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 88
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 88
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 88
• 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 54
• 108091008324 binding proteins Proteins 0.000 claims abstract description 54
• 238000002560 therapeutic procedure Methods 0.000 claims abstract description 48
• 238000004519 manufacturing process Methods 0.000 claims abstract description 34
• 102000014150 Interferons Human genes 0.000 claims abstract description 31
• 108010050904 Interferons Proteins 0.000 claims abstract description 31
• 102100037907 High mobility group protein B1 Human genes 0.000 claims abstract description 24
• 102000015696 Interleukins Human genes 0.000 claims abstract description 24
• 108010063738 Interleukins Proteins 0.000 claims abstract description 24
• 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 claims abstract description 24
• 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 claims abstract description 24
• 230000006052 T cell proliferation Effects 0.000 claims abstract description 24
• 230000000259 anti-tumor effect Effects 0.000 claims abstract description 24
• 229940047122 interleukins Drugs 0.000 claims abstract description 23
• 230000028993 immune response Effects 0.000 claims abstract description 17
• 230000035755 proliferation Effects 0.000 claims abstract description 16
• 238000011319 anticancer therapy Methods 0.000 claims abstract description 15
• 230000002924 anti-infective effect Effects 0.000 claims abstract description 13
• 230000000840 anti-viral effect Effects 0.000 claims abstract description 13
• 230000006698 induction Effects 0.000 claims abstract description 11
• 230000001225 therapeutic effect Effects 0.000 claims abstract description 8
• 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 7
• 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims abstract 3
• 108700010013 HMGB1 Proteins 0.000 claims abstract 3
• 101150021904 HMGB1 gene Proteins 0.000 claims abstract 3
• 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 130
• 108010074708 B7-H1 Antigen Proteins 0.000 claims description 100
• 102000008096 B7-H1 Antigen Human genes 0.000 claims description 97
• 108091033409 CRISPR Proteins 0.000 claims description 87
• 230000027455 binding Effects 0.000 claims description 74
• 239000012634 fragment Substances 0.000 claims description 68
• 210000000822 natural killer cell Anatomy 0.000 claims description 68
• 210000001616 monocyte Anatomy 0.000 claims description 64
• 238000012239 gene modification Methods 0.000 claims description 62
• 230000005017 genetic modification Effects 0.000 claims description 62
• 235000013617 genetically modified food Nutrition 0.000 claims description 62
• 210000000066 myeloid cell Anatomy 0.000 claims description 57
• 102000006992 Interferon-alpha Human genes 0.000 claims description 51
• 108010047761 Interferon-alpha Proteins 0.000 claims description 51
• 239000003814 drug Substances 0.000 claims description 51
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 48
• -1 PDGF Proteins 0.000 claims description 48
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 47
• 102000003996 Interferon-beta Human genes 0.000 claims description 43
• 108090000467 Interferon-beta Proteins 0.000 claims description 43
• 229960001388 interferon-beta Drugs 0.000 claims description 43
• 108010074328 Interferon-gamma Proteins 0.000 claims description 41
• 102000008070 Interferon-gamma Human genes 0.000 claims description 40
• 201000011510 cancer Diseases 0.000 claims description 40
• 229960003130 interferon gamma Drugs 0.000 claims description 40
• 238000010354 CRISPR gene editing Methods 0.000 claims description 38
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 37
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims description 36
• 230000004927 fusion Effects 0.000 claims description 35
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 34
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 34
• 102000003814 Interleukin-10 Human genes 0.000 claims description 33
• 108090000174 Interleukin-10 Proteins 0.000 claims description 33
• 108020004999 messenger RNA Proteins 0.000 claims description 33
• 102000013462 Interleukin-12 Human genes 0.000 claims description 32
• 108010065805 Interleukin-12 Proteins 0.000 claims description 32
• 229940002612 prodrug Drugs 0.000 claims description 30
• 239000000651 prodrug Substances 0.000 claims description 30
• 102000003810 Interleukin-18 Human genes 0.000 claims description 27
• 108090000171 Interleukin-18 Proteins 0.000 claims description 27
• 241000700605 Viruses Species 0.000 claims description 27
• 208000005017 glioblastoma Diseases 0.000 claims description 27
• 239000000203 mixture Substances 0.000 claims description 27
• 230000000770 proinflammatory effect Effects 0.000 claims description 27
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 26
• 102100023688 Eotaxin Human genes 0.000 claims description 26
• 108090000172 Interleukin-15 Proteins 0.000 claims description 26
• 102000003812 Interleukin-15 Human genes 0.000 claims description 26
• IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 claims description 26
• 229960002963 ganciclovir Drugs 0.000 claims description 26
• 239000003112 inhibitor Substances 0.000 claims description 26
• 229940124597 therapeutic agent Drugs 0.000 claims description 26
• 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 25
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims description 25
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims description 25
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 25
• 210000004881 tumor cell Anatomy 0.000 claims description 25
• 102100023702 C-C motif chemokine 13 Human genes 0.000 claims description 24
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 claims description 24
• 108090001005 Interleukin-6 Proteins 0.000 claims description 24
• 102000004889 Interleukin-6 Human genes 0.000 claims description 24
• 102100023705 C-C motif chemokine 14 Human genes 0.000 claims description 23
• 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 23
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims description 23
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 claims description 23
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 claims description 23
• 102100030704 Interleukin-21 Human genes 0.000 claims description 23
• 102100036154 Platelet basic protein Human genes 0.000 claims description 23
• 108010074108 interleukin-21 Proteins 0.000 claims description 23
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 22
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 22
• 229940079593 drug Drugs 0.000 claims description 22
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 22
• 230000000295 complement effect Effects 0.000 claims description 21
• 239000013603 viral vector Substances 0.000 claims description 21
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 20
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 20
• 108020004705 Codon Proteins 0.000 claims description 19
• 208000015181 infectious disease Diseases 0.000 claims description 19
• 108010002586 Interleukin-7 Proteins 0.000 claims description 18
• 150000001413 amino acids Chemical class 0.000 claims description 18
• 102000004452 Arginase Human genes 0.000 claims description 17
• 108700024123 Arginases Proteins 0.000 claims description 17
• 108090000978 Interleukin-4 Proteins 0.000 claims description 17
• 229960001603 tamoxifen Drugs 0.000 claims description 17
• 238000013518 transcription Methods 0.000 claims description 17
• 230000035897 transcription Effects 0.000 claims description 17
• 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 15
• 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 15
• 102100035304 Lymphotactin Human genes 0.000 claims description 15
• 101710098940 Pro-epidermal growth factor Proteins 0.000 claims description 15
• 108091008874 T cell receptors Proteins 0.000 claims description 15
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 15
• 238000011282 treatment Methods 0.000 claims description 15
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 14
• 102100021935 C-C motif chemokine 26 Human genes 0.000 claims description 14
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 14
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims description 14
• 102000000589 Interleukin-1 Human genes 0.000 claims description 14
• 108010002352 Interleukin-1 Proteins 0.000 claims description 14
• 108010002350 Interleukin-2 Proteins 0.000 claims description 14
• 102000000588 Interleukin-2 Human genes 0.000 claims description 14
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 14
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 14
• 239000000427 antigen Substances 0.000 claims description 14
• 108091007433 antigens Proteins 0.000 claims description 14
• 102000036639 antigens Human genes 0.000 claims description 14
• 150000003384 small molecules Chemical class 0.000 claims description 14
• 208000003174 Brain Neoplasms Diseases 0.000 claims description 13
• 102100036849 C-C motif chemokine 24 Human genes 0.000 claims description 13
• 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 13
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 claims description 13
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims description 13
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 13
• 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 claims description 13
• 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 claims description 13
• 230000000694 effects Effects 0.000 claims description 13
• 108020001507 fusion proteins Proteins 0.000 claims description 13
• 102000037865 fusion proteins Human genes 0.000 claims description 13
• 239000003446 ligand Substances 0.000 claims description 13
• 210000000274 microglia Anatomy 0.000 claims description 13
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims description 13
• 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 12
• 101710112613 C-C motif chemokine 13 Proteins 0.000 claims description 12
• 102100036842 C-C motif chemokine 19 Human genes 0.000 claims description 12
• 102100021936 C-C motif chemokine 27 Human genes 0.000 claims description 12
• 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims description 12
• 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims description 12
• 101710139422 Eotaxin Proteins 0.000 claims description 12
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 claims description 12
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims description 12
• 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 claims description 12
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims description 12
• 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 claims description 12
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 claims description 12
• 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims description 12
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 claims description 12
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims description 12
• 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims description 12
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 claims description 12
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 claims description 12
• 102100026236 Interleukin-8 Human genes 0.000 claims description 12
• 108700012411 TNFSF10 Proteins 0.000 claims description 12
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 12
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims description 12
• 238000013519 translation Methods 0.000 claims description 12
• 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 11
• 101710155833 C-C motif chemokine 8 Proteins 0.000 claims description 11
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 claims description 11
• 102000011727 Caspases Human genes 0.000 claims description 11
• 108010076667 Caspases Proteins 0.000 claims description 11
• 101150021185 FGF gene Proteins 0.000 claims description 11
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 claims description 11
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 11
• 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 claims description 11
• 101100222381 Homo sapiens CXCL11 gene Proteins 0.000 claims description 11
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims description 11
• 101100222387 Mus musculus Cxcl15 gene Proteins 0.000 claims description 11
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 11
• 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 claims description 11
• 102000006601 Thymidine Kinase Human genes 0.000 claims description 11
• 108020004440 Thymidine kinase Proteins 0.000 claims description 11
• 238000002659 cell therapy Methods 0.000 claims description 11
• WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 11
• 241000700584 Simplexvirus Species 0.000 claims description 10
• 102000015694 estrogen receptors Human genes 0.000 claims description 10
• 108010038795 estrogen receptors Proteins 0.000 claims description 10
• 206010006187 Breast cancer Diseases 0.000 claims description 9
• 208000026310 Breast neoplasm Diseases 0.000 claims description 9
• 230000003110 anti-inflammatory effect Effects 0.000 claims description 9
• 239000002246 antineoplastic agent Substances 0.000 claims description 9
• 208000020816 lung neoplasm Diseases 0.000 claims description 9
• 238000012546 transfer Methods 0.000 claims description 9
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 8
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 8
• 206010029260 Neuroblastoma Diseases 0.000 claims description 8
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 claims description 8
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 claims description 8
• 208000000277 Splenic Neoplasms Diseases 0.000 claims description 8
• 208000005718 Stomach Neoplasms Diseases 0.000 claims description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
• 229940082789 erbitux Drugs 0.000 claims description 8
• 206010017758 gastric cancer Diseases 0.000 claims description 8
• 238000002347 injection Methods 0.000 claims description 8
• 239000007924 injection Substances 0.000 claims description 8
• 201000007270 liver cancer Diseases 0.000 claims description 8
• 208000014018 liver neoplasm Diseases 0.000 claims description 8
• 201000005202 lung cancer Diseases 0.000 claims description 8
• 201000002471 spleen cancer Diseases 0.000 claims description 8
• 201000011549 stomach cancer Diseases 0.000 claims description 8
• 206010018338 Glioma Diseases 0.000 claims description 7
• 108010065637 Interleukin-23 Proteins 0.000 claims description 7
• 102000013264 Interleukin-23 Human genes 0.000 claims description 7
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 7
• 239000003795 chemical substances by application Substances 0.000 claims description 7
• 208000029742 colonic neoplasm Diseases 0.000 claims description 7
• 201000010099 disease Diseases 0.000 claims description 7
• 230000002401 inhibitory effect Effects 0.000 claims description 7
• 229940079322 interferon Drugs 0.000 claims description 7
• 229940043355 kinase inhibitor Drugs 0.000 claims description 7
• 108010019677 lymphotactin Proteins 0.000 claims description 7
• 239000003757 phosphotransferase inhibitor Substances 0.000 claims description 7
• 206010009944 Colon cancer Diseases 0.000 claims description 6
• 208000032612 Glial tumor Diseases 0.000 claims description 6
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 6
• 206010060862 Prostate cancer Diseases 0.000 claims description 6
• 208000002495 Uterine Neoplasms Diseases 0.000 claims description 6
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 6
• 208000026037 malignant tumor of neck Diseases 0.000 claims description 6
• 230000005855 radiation Effects 0.000 claims description 6
• 239000000126 substance Substances 0.000 claims description 6
• 206010046766 uterine cancer Diseases 0.000 claims description 6
• 230000002159 abnormal effect Effects 0.000 claims description 5
• 230000008859 change Effects 0.000 claims description 5
• 230000005764 inhibitory process Effects 0.000 claims description 5
• 230000004048 modification Effects 0.000 claims description 5
• 238000012986 modification Methods 0.000 claims description 5
• 238000005457 optimization Methods 0.000 claims description 5
• 238000001959 radiotherapy Methods 0.000 claims description 5
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 4
• 241000894006 Bacteria Species 0.000 claims description 4
• 102100024217 CAMPATH-1 antigen Human genes 0.000 claims description 4
• 108010065524 CD52 Antigen Proteins 0.000 claims description 4
• 101150029707 ERBB2 gene Proteins 0.000 claims description 4
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 4
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 4
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 4
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 4
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
• 102100034256 Mucin-1 Human genes 0.000 claims description 4
• 108010008707 Mucin-1 Proteins 0.000 claims description 4
• 102100023123 Mucin-16 Human genes 0.000 claims description 4
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
• 102000003425 Tyrosinase Human genes 0.000 claims description 4
• 108060008724 Tyrosinase Proteins 0.000 claims description 4
• 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 4
• YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims description 4
• 229960002932 anastrozole Drugs 0.000 claims description 4
• 239000003242 anti bacterial agent Substances 0.000 claims description 4
• 239000003443 antiviral agent Substances 0.000 claims description 4
• 238000006471 dimerization reaction Methods 0.000 claims description 4
• 239000000411 inducer Substances 0.000 claims description 4
• 229960003881 letrozole Drugs 0.000 claims description 4
• HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 claims description 4
• 230000035939 shock Effects 0.000 claims description 4
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims description 4
• 239000005483 tyrosine kinase inhibitor Substances 0.000 claims description 4
• 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 claims description 4
• 238000011357 CAR T-cell therapy Methods 0.000 claims description 3
• 241000991587 Enterovirus C Species 0.000 claims description 3
• 210000003714 granulocyte Anatomy 0.000 claims description 3
• 229940088597 hormone Drugs 0.000 claims description 3
• 239000005556 hormone Substances 0.000 claims description 3
• 210000003734 kidney Anatomy 0.000 claims description 3
• 230000000174 oncolytic effect Effects 0.000 claims description 2
• 239000005482 chemotactic factor Substances 0.000 claims 12
• 108091079001 CRISPR RNA Proteins 0.000 claims 5
• 230000024245 cell differentiation Effects 0.000 claims 5
• 229940124650 anti-cancer therapies Drugs 0.000 claims 4
• 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 claims 3
• 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 claims 3
• 108090000193 Interleukin-1 beta Proteins 0.000 claims 3
• 102000003777 Interleukin-1 beta Human genes 0.000 claims 3
• 206010010144 Completed suicide Diseases 0.000 claims 2
• 102100021592 Interleukin-7 Human genes 0.000 claims 2
• 238000010317 ablation therapy Methods 0.000 claims 2
• 238000011203 antimicrobial therapy Methods 0.000 claims 2
• 239000003153 chemical reaction reagent Substances 0.000 claims 2
• 230000004060 metabolic process Effects 0.000 claims 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
• 201000009030 Carcinoma Diseases 0.000 claims 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 1
• 230000003213 activating effect Effects 0.000 claims 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 claims 1
• 239000012829 chemotherapy agent Substances 0.000 claims 1
• 238000005034 decoration Methods 0.000 claims 1
• 235000013601 eggs Nutrition 0.000 claims 1
• 239000002532 enzyme inhibitor Substances 0.000 claims 1
• 229940125532 enzyme inhibitor Drugs 0.000 claims 1
• 229940011871 estrogen Drugs 0.000 claims 1
• 239000000262 estrogen Substances 0.000 claims 1
• 238000007689 inspection Methods 0.000 claims 1
• 210000001161 mammalian embryo Anatomy 0.000 claims 1
• 235000013372 meat Nutrition 0.000 claims 1
• 231100000614 poison Toxicity 0.000 claims 1
• 230000007096 poisonous effect Effects 0.000 claims 1
• 230000008439 repair process Effects 0.000 claims 1
• 150000003431 steroids Chemical class 0.000 claims 1
• DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
• 229960000575 trastuzumab Drugs 0.000 claims 1
• 230000007306 turnover Effects 0.000 claims 1
• 102000019034 Chemokines Human genes 0.000 abstract description 61
• 108010012236 Chemokines Proteins 0.000 abstract description 61
• 102000004127 Cytokines Human genes 0.000 abstract description 36
• 108090000695 Cytokines Proteins 0.000 abstract description 36
• 229940047124 interferons Drugs 0.000 abstract description 24
• 230000001629 suppression Effects 0.000 abstract description 7
• 230000001965 increasing effect Effects 0.000 abstract description 5
• 230000002688 persistence Effects 0.000 abstract description 4
• 102100023990 60S ribosomal protein L17 Human genes 0.000 abstract 1
• 230000020411 cell activation Effects 0.000 abstract 1
• 235000018102 proteins Nutrition 0.000 description 181
• 230000014509 gene expression Effects 0.000 description 52
• 230000001105 regulatory effect Effects 0.000 description 44
• 108020005004 Guide RNA Proteins 0.000 description 40
• 230000001939 inductive effect Effects 0.000 description 22
• 101001025337 Homo sapiens High mobility group protein B1 Proteins 0.000 description 21
• 241000713666 Lentivirus Species 0.000 description 20
• 230000004913 activation Effects 0.000 description 20
• 239000002158 endotoxin Substances 0.000 description 20
• 229920006008 lipopolysaccharide Polymers 0.000 description 20
• 229920002477 rna polymer Polymers 0.000 description 17
• 102000000704 Interleukin-7 Human genes 0.000 description 16
• 210000005260 human cell Anatomy 0.000 description 16
• 230000004069 differentiation Effects 0.000 description 15
• 210000003527 eukaryotic cell Anatomy 0.000 description 15
• 238000002474 experimental method Methods 0.000 description 15
• 230000006870 function Effects 0.000 description 15
• 230000014759 maintenance of location Effects 0.000 description 15
• 102000001301 EGF receptor Human genes 0.000 description 14
• 108060006698 EGF receptor Proteins 0.000 description 14
• 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 14
• 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 14
• 229940024606 amino acid Drugs 0.000 description 14
• 235000001014 amino acid Nutrition 0.000 description 14
• 238000012258 culturing Methods 0.000 description 14
• 102000053602 DNA Human genes 0.000 description 13
• 108020004414 DNA Proteins 0.000 description 13
• 230000000735 allogeneic effect Effects 0.000 description 13
• 230000014616 translation Effects 0.000 description 13
• 102000004190 Enzymes Human genes 0.000 description 12
• 108090000790 Enzymes Proteins 0.000 description 12
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 12
• 241001465754 Metazoa Species 0.000 description 12
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 12
• 238000000684 flow cytometry Methods 0.000 description 12
• 108090000765 processed proteins & peptides Proteins 0.000 description 12
• 230000001270 agonistic effect Effects 0.000 description 11
• 210000004698 lymphocyte Anatomy 0.000 description 11
• 239000002207 metabolite Substances 0.000 description 11
• 210000000987 immune system Anatomy 0.000 description 10
• 230000001506 immunosuppresive effect Effects 0.000 description 10
• 231100000433 cytotoxic Toxicity 0.000 description 9
• 230000001472 cytotoxic effect Effects 0.000 description 9
• 230000004083 survival effect Effects 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 8
• 230000004044 response Effects 0.000 description 8
• 230000004614 tumor growth Effects 0.000 description 8
• 102000006354 HLA-DR Antigens Human genes 0.000 description 7
• 108010058597 HLA-DR Antigens Proteins 0.000 description 7
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 7
• 206010039491 Sarcoma Diseases 0.000 description 7
• 238000013019 agitation Methods 0.000 description 7
• 210000004556 brain Anatomy 0.000 description 7
• 238000002955 isolation Methods 0.000 description 7
• 230000001404 mediated effect Effects 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 230000000638 stimulation Effects 0.000 description 7
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 6
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 6
• 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 6
• 108050008953 Melanoma-associated antigen Proteins 0.000 description 6
• 102100026497 Zinc finger protein 654 Human genes 0.000 description 6
• 230000006907 apoptotic process Effects 0.000 description 6
• 238000002512 chemotherapy Methods 0.000 description 6
• 238000003776 cleavage reaction Methods 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 230000018109 developmental process Effects 0.000 description 6
• 231100000673 dose–response relationship Toxicity 0.000 description 6
• 239000012636 effector Substances 0.000 description 6
• 238000010362 genome editing Methods 0.000 description 6
• 229940022353 herceptin Drugs 0.000 description 6
• 125000003729 nucleotide group Chemical group 0.000 description 6
• 208000008443 pancreatic carcinoma Diseases 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 102000005962 receptors Human genes 0.000 description 6
• 108020003175 receptors Proteins 0.000 description 6
• 230000007017 scission Effects 0.000 description 6
• 238000010361 transduction Methods 0.000 description 6
• 238000011870 unpaired t-test Methods 0.000 description 6
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 5
• 208000008839 Kidney Neoplasms Diseases 0.000 description 5
• 206010033128 Ovarian cancer Diseases 0.000 description 5
• 206010061535 Ovarian neoplasm Diseases 0.000 description 5
• 101710149136 Protein Vpr Proteins 0.000 description 5
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 5
• 206010038389 Renal cancer Diseases 0.000 description 5
• 208000000453 Skin Neoplasms Diseases 0.000 description 5
• 238000010459 TALEN Methods 0.000 description 5
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 5
• 230000002411 adverse Effects 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 239000003636 conditioned culture medium Substances 0.000 description 5
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 5
• 210000004443 dendritic cell Anatomy 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 201000010982 kidney cancer Diseases 0.000 description 5
• 210000004980 monocyte derived macrophage Anatomy 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 201000002528 pancreatic cancer Diseases 0.000 description 5
• 201000000849 skin cancer Diseases 0.000 description 5
• 125000006850 spacer group Chemical group 0.000 description 5
• 235000000346 sugar Nutrition 0.000 description 5
• 238000012384 transportation and delivery Methods 0.000 description 5
• 210000004981 tumor-associated macrophage Anatomy 0.000 description 5
• MHJBZVSGOZTKRH-IZHYLOQSSA-N 4-Hydroxy-N-desmethyltamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCNC)=CC=1)/C1=CC=C(O)C=C1 MHJBZVSGOZTKRH-IZHYLOQSSA-N 0.000 description 4
• 239000013607 AAV vector Substances 0.000 description 4
• 108010088751 Albumins Proteins 0.000 description 4
• BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 4
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 4
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 4
• 238000002965 ELISA Methods 0.000 description 4
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 4
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
• 206010062016 Immunosuppression Diseases 0.000 description 4
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 4
• 241000699670 Mus sp. Species 0.000 description 4
• 230000000118 anti-neoplastic effect Effects 0.000 description 4
• 229940126573 antibacterial therapeutic Drugs 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 210000003169 central nervous system Anatomy 0.000 description 4
• 230000003750 conditioning effect Effects 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 230000037451 immune surveillance Effects 0.000 description 4
• 239000002955 immunomodulating agent Substances 0.000 description 4
• 229940121354 immunomodulator Drugs 0.000 description 4
• 230000001024 immunotherapeutic effect Effects 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 230000002757 inflammatory effect Effects 0.000 description 4
• 210000004985 myeloid-derived suppressor cell Anatomy 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• 230000001737 promoting effect Effects 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 230000011664 signaling Effects 0.000 description 4
• 238000001356 surgical procedure Methods 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 108091006106 transcriptional activators Proteins 0.000 description 4
• 230000026683 transduction Effects 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• 102100027211 Albumin Human genes 0.000 description 3
• 102100023635 Alpha-fetoprotein Human genes 0.000 description 3
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 3
• 238000010453 CRISPR/Cas method Methods 0.000 description 3
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
• 108700010070 Codon Usage Proteins 0.000 description 3
• 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 3
• 102100031780 Endonuclease Human genes 0.000 description 3
• 108010042407 Endonucleases Proteins 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 102000008100 Human Serum Albumin Human genes 0.000 description 3
• 108091006905 Human Serum Albumin Proteins 0.000 description 3
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 3
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 3
• 108010067003 Interleukin-33 Proteins 0.000 description 3
• 102000017761 Interleukin-33 Human genes 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 239000012270 PD-1 inhibitor Substances 0.000 description 3
• 239000012668 PD-1-inhibitor Substances 0.000 description 3
• 108700019718 SAM Domain and HD Domain-Containing Protein 1 Proteins 0.000 description 3
• 101150114242 SAMHD1 gene Proteins 0.000 description 3
• 108700019146 Transgenes Proteins 0.000 description 3
• 238000009098 adjuvant therapy Methods 0.000 description 3
• 230000006023 anti-tumor response Effects 0.000 description 3
• 229940034982 antineoplastic agent Drugs 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 229940127089 cytotoxic agent Drugs 0.000 description 3
• 230000002708 enhancing effect Effects 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 238000011275 oncology therapy Methods 0.000 description 3
• 238000001543 one-way ANOVA Methods 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 229940121655 pd-1 inhibitor Drugs 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 210000002307 prostate Anatomy 0.000 description 3
• 102000016914 ras Proteins Human genes 0.000 description 3
• 230000007115 recruitment Effects 0.000 description 3
• 238000002271 resection Methods 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 239000000878 small molecule-drug conjugate Substances 0.000 description 3
• 210000000278 spinal cord Anatomy 0.000 description 3
• 210000002536 stromal cell Anatomy 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 description 2
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 2
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 2
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 102100022338 Integrin alpha-M Human genes 0.000 description 2
• 108010005716 Interferon beta-1a Proteins 0.000 description 2
• 108010005714 Interferon beta-1b Proteins 0.000 description 2
• 108090000176 Interleukin-13 Proteins 0.000 description 2
• 102000010782 Interleukin-7 Receptors Human genes 0.000 description 2
• 108010038498 Interleukin-7 Receptors Proteins 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 108091030071 RNAI Proteins 0.000 description 2
• 108091027981 Response element Proteins 0.000 description 2
• 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 2
• 230000006044 T cell activation Effects 0.000 description 2
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
• 102100035100 Transcription factor p65 Human genes 0.000 description 2
• 108010052104 Viral Regulatory and Accessory Proteins Proteins 0.000 description 2
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 210000005006 adaptive immune system Anatomy 0.000 description 2
• TXUZVZSFRXZGTL-QPLCGJKRSA-N afimoxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=C(O)C=C1 TXUZVZSFRXZGTL-QPLCGJKRSA-N 0.000 description 2
• 229950003105 afimoxifene Drugs 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 230000005809 anti-tumor immunity Effects 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 238000005415 bioluminescence Methods 0.000 description 2
• 230000029918 bioluminescence Effects 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• 125000000837 carbohydrate group Chemical group 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 108700010039 chimeric receptor Proteins 0.000 description 2
• 230000004186 co-expression Effects 0.000 description 2
• 206010052015 cytokine release syndrome Diseases 0.000 description 2
• 230000001461 cytolytic effect Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000004064 dysfunction Effects 0.000 description 2
• 210000002889 endothelial cell Anatomy 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 230000009368 gene silencing by RNA Effects 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 230000009931 harmful effect Effects 0.000 description 2
• 210000003128 head Anatomy 0.000 description 2
• 210000002443 helper t lymphocyte Anatomy 0.000 description 2
• 230000001146 hypoxic effect Effects 0.000 description 2
• 229960002751 imiquimod Drugs 0.000 description 2
• DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
• 230000002519 immonomodulatory effect Effects 0.000 description 2
• 230000005965 immune activity Effects 0.000 description 2
• 230000006058 immune tolerance Effects 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 210000005007 innate immune system Anatomy 0.000 description 2
• 229960004461 interferon beta-1a Drugs 0.000 description 2
• 229960003161 interferon beta-1b Drugs 0.000 description 2
• 230000004068 intracellular signaling Effects 0.000 description 2
• 238000007917 intracranial administration Methods 0.000 description 2
• 238000010234 longitudinal analysis Methods 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• 230000002101 lytic effect Effects 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 210000003071 memory t lymphocyte Anatomy 0.000 description 2
• 210000000581 natural killer T-cell Anatomy 0.000 description 2
• 210000003739 neck Anatomy 0.000 description 2
• 230000001613 neoplastic effect Effects 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 210000001672 ovary Anatomy 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 238000003752 polymerase chain reaction Methods 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 230000018883 protein targeting Effects 0.000 description 2
• 150000003212 purines Chemical class 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 210000003289 regulatory T cell Anatomy 0.000 description 2
• 230000008672 reprogramming Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 102220101652 rs878854761 Human genes 0.000 description 2
• 108091006024 signal transducing proteins Proteins 0.000 description 2
• 102000034285 signal transducing proteins Human genes 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 230000008093 supporting effect Effects 0.000 description 2
• 230000002463 transducing effect Effects 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• 210000004291 uterus Anatomy 0.000 description 2
• 230000003612 virological effect Effects 0.000 description 2
• 230000003442 weekly effect Effects 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• PCLCDPVEEFVAAQ-UHFFFAOYSA-N BCA 1 Chemical compound CC(CO)CCCC(C)C1=CCC(C)(O)C1CC2=C(O)C(O)CCC2=O PCLCDPVEEFVAAQ-UHFFFAOYSA-N 0.000 description 1
• 108010081589 Becaplermin Proteins 0.000 description 1
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 1
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 102400000583 C80 Human genes 0.000 description 1
• 101800001507 C80 Proteins 0.000 description 1
• 238000011523 CAR-T cell immunotherapy Methods 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• 101150093802 CXCL1 gene Proteins 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 108010083698 Chemokine CCL26 Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 206010052358 Colorectal cancer metastatic Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• 206010050685 Cytokine storm Diseases 0.000 description 1
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 102100031107 Disintegrin and metalloproteinase domain-containing protein 11 Human genes 0.000 description 1
• 101710121366 Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 description 1
• 206010015548 Euthanasia Diseases 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 208000014061 Extranodal Extension Diseases 0.000 description 1
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 108090000331 Firefly luciferases Proteins 0.000 description 1
• 102000013818 Fractalkine Human genes 0.000 description 1
• 206010061968 Gastric neoplasm Diseases 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101100441523 Homo sapiens CXCL5 gene Proteins 0.000 description 1
• 101000856606 Homo sapiens GTP-binding protein GEM Proteins 0.000 description 1
• 101001058904 Homo sapiens Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101001014636 Homo sapiens Golgin subfamily A member 4 Proteins 0.000 description 1
• 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 1
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
• 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 101150083678 IL2 gene Proteins 0.000 description 1
• 101150025117 IL3 gene Proteins 0.000 description 1
• 101150015560 IL5 gene Proteins 0.000 description 1
• 101150101999 IL6 gene Proteins 0.000 description 1
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 1
• 102000037982 Immune checkpoint proteins Human genes 0.000 description 1
• 108091008036 Immune checkpoint proteins Proteins 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 102100020990 Interferon lambda-1 Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 101800003050 Interleukin-16 Proteins 0.000 description 1
• 102000049772 Interleukin-16 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 102100020880 Kit ligand Human genes 0.000 description 1
• 101710177504 Kit ligand Proteins 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
• 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
• 101710164418 Movement protein TGB2 Proteins 0.000 description 1
• 101100508567 Mus musculus Il7 gene Proteins 0.000 description 1
• 206010061309 Neoplasm progression Diseases 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 102100022396 Nucleosome assembly protein 1-like 4 Human genes 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 108091036407 Polyadenylation Proteins 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710149109 Protein Vpx Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100021225 Serine hydroxymethyltransferase, cytosolic Human genes 0.000 description 1
• 108700025832 Serum Response Element Proteins 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 240000003243 Thuja occidentalis Species 0.000 description 1
• 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 1
• 102100027188 Thyroid peroxidase Human genes 0.000 description 1
• 101710113649 Thyroid peroxidase Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
• 102400001320 Transforming growth factor alpha Human genes 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 101710165741 Virion-associated protein Proteins 0.000 description 1
• 241001492404 Woodchuck hepatitis virus Species 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 230000033289 adaptive immune response Effects 0.000 description 1
• 229960001570 ademetionine Drugs 0.000 description 1
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
• 229960003767 alanine Drugs 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 150000001408 amides Chemical group 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 230000003042 antagnostic effect Effects 0.000 description 1
• 230000002424 anti-apoptotic effect Effects 0.000 description 1
• 238000011394 anticancer treatment Methods 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 230000005975 antitumor immune response Effects 0.000 description 1
• 229960003121 arginine Drugs 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960005261 aspartic acid Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000003140 astrocytic effect Effects 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 230000014564 chemokine production Effects 0.000 description 1
• 201000002797 childhood leukemia Diseases 0.000 description 1
• 208000011654 childhood malignant neoplasm Diseases 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 238000012761 co-transfection Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 229940095074 cyclic amp Drugs 0.000 description 1
• 229960002433 cysteine Drugs 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 230000000254 damaging effect Effects 0.000 description 1
• 230000005860 defense response to virus Effects 0.000 description 1
• 229940124447 delivery agent Drugs 0.000 description 1
• 230000000779 depleting effect Effects 0.000 description 1
• 238000012938 design process Methods 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 229960003722 doxycycline Drugs 0.000 description 1
• XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
• 229940126534 drug product Drugs 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 230000008995 epigenetic change Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 238000010230 functional analysis Methods 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 230000002518 glial effect Effects 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 229960002989 glutamic acid Drugs 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960002743 glutamine Drugs 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 210000000224 granular leucocyte Anatomy 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 208000029824 high grade glioma Diseases 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229960002885 histidine Drugs 0.000 description 1
• 102000053685 human GEM Human genes 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 230000005931 immune cell recruitment Effects 0.000 description 1
• 230000005746 immune checkpoint blockade Effects 0.000 description 1
• 230000007124 immune defense Effects 0.000 description 1
• 102000027596 immune receptors Human genes 0.000 description 1
• 108091008915 immune receptors Proteins 0.000 description 1
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 108090000681 interleukin 20 Proteins 0.000 description 1
• 102000004114 interleukin 20 Human genes 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 208000021601 lentivirus infection Diseases 0.000 description 1
• 229960003136 leucine Drugs 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 108020001756 ligand binding domains Proteins 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 208000037841 lung tumor Diseases 0.000 description 1
• 229960003646 lysine Drugs 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 201000011614 malignant glioma Diseases 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 208000021039 metastatic melanoma Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960004452 methionine Drugs 0.000 description 1
• 230000006724 microglial activation Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 238000001565 modulated differential scanning calorimetry Methods 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 210000003887 myelocyte Anatomy 0.000 description 1
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
• 230000037125 natural defense Effects 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 230000012223 nuclear import Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 210000003668 pericyte Anatomy 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 238000011422 pharmacological therapy Methods 0.000 description 1
• 229960005190 phenylalanine Drugs 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 230000010287 polarization Effects 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 229940124606 potential therapeutic agent Drugs 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 208000030266 primary brain neoplasm Diseases 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 229960002429 proline Drugs 0.000 description 1
• 208000023958 prostate neoplasm Diseases 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 230000014493 regulation of gene expression Effects 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000012827 research and development Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 229940055619 selenocysteine Drugs 0.000 description 1
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
• 235000016491 selenocysteine Nutrition 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
• 229960001153 serine Drugs 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000011301 standard therapy Methods 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• 229960004964 temozolomide Drugs 0.000 description 1
• 238000011287 therapeutic dose Methods 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229960002898 threonine Drugs 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 239000003440 toxic substance Substances 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 102000052185 transforming growth factor beta receptor activity proteins Human genes 0.000 description 1
• 108700015056 transforming growth factor beta receptor activity proteins Proteins 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 230000005747 tumor angiogenesis Effects 0.000 description 1
• 230000005740 tumor formation Effects 0.000 description 1
• 230000005751 tumor progression Effects 0.000 description 1
• 229960004441 tyrosine Drugs 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 229960004295 valine Drugs 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 238000012447 xenograft mouse model Methods 0.000 description 1